Acute and chronic estrogen supplementation decreases uterine sympathetic innervation in ovariectomized adult virgin rats by Smith, P. G. et al.
Histol Histopathol (2001) 16: 989-996 
http://www.ehu.es/histol-histopathol 
Histology and 
Histopathology 
Cellular and Molecular Biology 
Acute and chronic estrogen supplementation 
decreases uterine sympathetic innervation 
in ovariectomized adult virgin rats 
E.V. Zoubinal, A.L. Mize2, R.H. Alper2 and P.G. Smith1 
Department of Molecular and Integrative Physiology, and R.L. Smith Mental Retardation Research Center and 0 3 E T .  2001 
*Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA 
Summary. Uterine innervation undergoes substantial 
reorganization associated with changes in reproductive 
status. Nerves innervating the uterus are decreased in 
U 
pregnancy and puberty, and even the normal rodent 
estrous cycle is characterized by fluctuations in numbers 
of myometrial nerve fibers. During the follicular 
(proestrus/estrous) phase of the estrous cycle, intact 
nerves are rapidly depleted and then return over the next 
2-3 days in the luteal (metestrus/diestrus) phase. We 
hypothesize that uterine nerve depletion is initiated by 
increased circulating estrogen in the follicular phase. 
However. studies have not shown whether estrogen can 
" 
reduce uterine innervation and, if so, whether the time 
course is compatible with the rapid changes observed in 
the estrous cycle. These questions were addressed in the 
present study. Mature ovariectomized virgin rats 
received 17-B-estradiol as a single injection (10 pg/kg 
s.c.) or chronically from timed-release pellets (0.1 
pglpellet for 3 weeks sustained release). Total (protein 
gene-product 9.5-immunoreactive) and sympathetic 
(dopamine B-hydroxylase-immunoreactive) uterine 
innervation was assessed quantitatively. Both total and 
sympathetic innervation was abundant in uterine 
longitudinal smooth muscle of ovariectomized rats. 
However, following acute or chronic estrogen 
administration, total and sympathetic fiber numbers were 
markedly decreased. This was not due to altered uterine 
size, as reductions persisted after correcting for size 
differences. Our results indicate that sympathetic nerves 
are lost from uterine smooth muscle after estradiol 
treatment in a manner similar to that seen in the intact 
animal during estrus and pregnancy. This suggests that 
the rise in estradiol prior to estrus is sufficient to deplete 
uterine sympathetic innervation. 
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Introduction 
Sympathetic innervation of the mammalian uterus is 
characterized by a high capacity for plasticity. From 
birth through puberty, uterine sympathetic nerves density 
increases progressively. However, at the time of the first 
ovulation, the number of nerves displaying 
noradrenergic markers decreases markedly (Brauer et al., 
1992). Similarly, pregnancy is associated with reductions 
in uterine sympathetic axon markers, including 
norepinephrine and its biosynthetic enzymes (Sjoberg, 
1968). This is due to an actual reduction of nerve 
numbers in pregnancy, as confirmed by immunostaining 
for the pan-neuronal marker, protein gene product (PGP) 
9.5 (Lundberg et al., 1988; Haase et al., 1997) and by 
electron microscopic ultrastructural analysis (Owman, 
1981; Sporrong et al. ,  1981).  Therefore, uterine 
innervation is  altered markedly as a function of 
development and pregnancy. 
Although the mechanisms governing these 
alterations are unclear, changes in levels of ovarian 
steroids have been implicated. In the pregnant guinea pig 
uterus, implantation of porcelain pellets to mimic 
concepta can elicit ute;ine nerve-degeneration if 
conducted in the presence of high levels of endogenous 
(Lundberg et al., 1989) or exogenous (Owman, 1981) 
ovarian sex steroids. Intra-uterine implantation of 
progesterone-containing pellets in guinea pigs can 
induce a local loss  of uterine sympathetic nerve 
fluorescence, possibly as a result of inhibition of 
noradrenaline biosynthesis (Bell and Malcolm, 1978, 
1988). Estrogen is also implicated in sympathetic nerve 
remodeling, as its administration to prepubertal rats 
prevents the normal developmental increase in uterine 
norepinephrine content (Brauer et al., 1995, 1999a,b). 
Moreover, because chronic estrogen also prevents the 
developmental increase PGP 9.5-immunoreactive (ir) 
nerve density, it has been suggested that this hormone 
mav inhibit normal develo~mental increases in nerve --- 
density or possibly induce degeneration (Brauer et al., 
1999a,b). Accordingly, ovarian steroid hormones are 
strongly implicated as determinants of uterine nerve 
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status in pregnancy and development. 
In addition to puberty and pregnancy, uterine 
innervation also varies as a function of the normal sexual 
cycle. In the rat, fertility is governed by the estrous 
cycle, which is similar to the menstrual cycle of primates 
but lasts only 4-5 days. The proestrus and estrus phases, 
which correspond to the follicular phase of the human 
menstrual cycle, are characterized by reductions in 
uterine sympathetic dopamine 13-hydroxylase (DBH)-ir 
nerves, as well as total PGP 9.5-ir innervation (Zoubina 
et al., 1998). These depletions coincide with dramatic 
reductions in structurally intact myometrial axons and 
increases in degenerating axon remnants. The presence 
2-3 days later of growth cones and increased fiber 
numbers indicates rapid regeneration of uterine 
innervation during metestrus and diestrus (Zoubina and 
Smith, 2000). These findings therefore indicate that 
cyclical degenerative and regenerative processes occur 
normally to sympathetic innervation during the rodent 
estrous cycle. 
Estrogen may be important for the cyclical changes 
in innervation seen during the estrous cycle. 
Degeneration during proestrus and estrus is preceded by 
increasing plasma estrogen, which begins in late diestrus 
(Freeman, 1988). However, it has not been determined 
whether either acute or chronic estrogen administration 
can elicit depletion of innervation of the adult virgin 
uterus. Moreover, unlike pregnancy and puberty where 
the decrease in nerve density apparently occurs over the 
course of at least several days (Owman et al., 1986; 
Brauer et al., 1992), degeneration of sympathetic nerves 
during the estrous cycle apparently begins within 24 
hours of the rise in plasma estrogen, and it is not clear 
whether this hormone can induce such dramatic effects 
on uterine innervation within such a short time frame. 
The present study was conducted to determine if 
exogenous estrogen modulates uterine nerve density of 
adult virgin rats deprived of endogenous estrogen by 
ovariectomy (OVX). In addition, short-term and long- 
term estrogen supplementations were compared to 
determine whether the actions of this steroid are 
consistent with changes in the intact animal during the 
estrous cycle, pregnancy, and puberty. 
w ere made aseptica\\y midway between \ow er ribs and 
crest of ileum, and both ovaries were isolated and 
removed. The incision was closed with suture clips (Fine 
Science Tools Inc., Foster City, CA, USA) and rats were 
allowed to recover before being returned to the animal 
facility. All experimental protocols adhered to NIH 
guidelines for laboratory animal care and were approved 
by the University of Kansas Medical Center Animal 
Care and Use Committee. 
Estrogen treatments 
For long-term estrogen treatment, rats were assigned 
randomly to receive 17-D-estradiol or placebo (7 rats per 
group). One week after OVX, rats were anesthetized as 
described above and a small incision was made in the 
nape of the neck. Pellets containing either placebo or 0.1 
mg 17-B-estradiol (Innovative Research of America, 
Toledo, OH) were implanted subcutaneously. These 
pellets provide sustained release for 3 weeks, achieving 
plasma estradiol levels comparable to those during the 
later stages of pregnancy (Bridges, 1984; Conrad et al., 
1994). Incisions were closed with suture and rats were 
allowed to recover before being returned to the animal 
facility. Two weeks later animals were sacrificed by 
decapitation and uterine tissues were harvested. 
In the acute treatment protocol, 4 rats each were 
randomly assigned to treatment or control groups. Seven 
days after OVX, animals received a single subcutaneous 
injection of either 17-B-estradiol (10 pglkg, Sigrna, St. 
Louis, MO, USA) or sesame oil vehicle alone. This dose 
of estradiol in OVX rats produces plasma estradiol levels 
similar to those during normal estrus (Medlock et al., 
1991; Viau and Meaney, 1991). Rats were killed by 
urethane overdose 24 hours following the injection and 
uterine tissues were collected. 
Serum estradiol determination 
In the chronic treatment group, trunk blood was 
collected for serum estradiol determination at the time of 
sacrifice. In the acute group, blood was collected from 
femoral vein under inhalation anesthesia with isoflurane 
at 30  minutes and 1 hour after injection of 17-13- 
estradiol or vehicle. 
~aterials and methods 
~ l ~ ~ d  samples were collected in E ~ ~ e n d o r f  tubes 
and immediately centrifuged at 10,000 rpm fo r  Animals and surgical ovariectomy 
minutes, serum was transferred to separate tubes and 
Female virgin 2-3 month old s p r a g u e - ~ a w 1 e y  stored at -20 'C for 1-2 weeks prior to assay. A "lid- 
(Harlan) rats were housed 2-3 per cage in a climate- phase 12'1 radioinmunoassay kit (Diagnostic Products 
controlled room with a 12h light-dark cycle starting at 8 Corporation, LOS Angeles, CA) was used to measure 
a.m, and received food and water ad libiturn. A total of serum estradiol. This assay had a lower limit of reliable 22 ovariectomized rats were included in  these 
detection of 38 pg/ml 2nd shows 
cross- experiments. 
reactivity to other hormones. Each sample was assayed Animals were anesthetized by intraperitoneaj 
in duplicate, injection of a mixture of ketamine hydrochloride (27.5 
P 'W York A ,  x a n e  
nssue processing ,d immunoflUoreSCenCe (2.5 Rompun, Miles, Shawnee KS, USA) and atropine sujfate p.24 mg/kg, 
vedcO' JOseph' 
b*ate.l incisions In all Ihe groups, horns tiss were wa expo~ed fixed and by n n i d h  immersion ercised~ i n  
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Zamboni's solution (Stefanini et al., 1967) for 3 hours, 
washed for 1 week in phosphate-buffered saline at 4 'C, 
embedded in gelatin-albumin mixture and frozen. Fresh 
tissue was also obtained from rats receiving estradiol or 
vehicle injection 1 week after OVX. Fifteen p m  
transverse sections were cut from the ovarian region of 
the uterus, since previous studies have shown that this is 
where changes in innervation during the normal estrous 
cycle are most prominent (Zoubina et al., 1998; Zoubina 
and Smith, 2000). Sections were thaw-mounted onto 
Colorfrost Plus microscope slides (Fisher), air-dried and 
fixed for 5 minutes in 100% methanol at -20 'C. 
Slides were rinsed in phosphate-buffered saline 
containing 0.3% Triton X-100, blocked for 20 minutes 
with 5% normal goat serum and 1% bovine serum 
albumin, and incubated overnight at 4 'C with primary 
rabbit polyclonal antisera to PGP 9.5 (1 :400, Biogenesis) 
or DBH (1:400, Eugene Tech). Both fixation methods 
yield satisfactory DBH immunostaining though the 
signal is stronger in fresh-frozen tissue with methanol 
fixation. Antibodies were previously characterized in 
this laboratory (Simons and Smith, 1994; Smith and Fan, 
1996) and specificity controls included omission of 
primary antisera and antigen preadsorption. Primary 
antibodies were visualized with goat anti-rabbit IgG 
conjugated to CY3 (1:400, Jackson ImmunoResearch). 
Slides were coverslipped with Fluoromount G and 
viewed with epifluorescence microscopy. Images were 
captured digitally with a DAGE 72 CCD camera and 
NIH Image software. 
Quantitative analysis of innervation 
PGP 9.5-ir and DBH-ir innervation was measured in 
longitudinal smooth muscle from transverse sections 
through the entire uterine horn 5-7 mm from the tubo- 
uterine junction, where cyclical changes are most 
prominent (Zoubina et al., 1998). Slides were coded and 
evaluated blindly. In each section, 4 quadrants located 
equidistant from each other and including the 
mesometrial, antimesometrial and intermesometrial 
regions were selected under brightfield illumination. 
Under epifluorescence illumination, images of these 
selected regions were captured digitally, and a stereology 
grid with an area corresponding to 0.25 mm2 and line 
intersects at 20 p m  intervals (NIH Image software) was 
superimposed randomly over the selected muscle field. 
The apparent percentage area of PGP 9.5-ir or DBH-ir 
nerves within the captured images was estimated by 
dividing all grid intersects overlying fluorescent nerve 
profiles by total grid intersects over the longitudinal 
smooth muscle, thus providing an index of nerve density. 
To determine the extent to which target size varied as a 
result of OVX and hormone treatments, smooth muscle 
area was measured planimetrically by tracing around the 
perimeters of the entire longitudinal muscle profile in 
brightfield images in the sections from which nerve 
density was determined. All values for target size 
presented refer to measurements from immersion-fixed 
tissue, which were slightly but not significantly lower 
than the fresh-frozen samples. To normalize innervation 
measurements for changes in target size, nerve density 
(i .e.  nerve area percentage measured above) was 
multiplied by the target area to provide an index of the 
total innervation. Data were compared using one-way 
analysis of variance with post hoc analysis by Student 
Newman-Keuls test. A probability of <0.05 was taken to 
indicate a statistically significant difference. 
Results 
Ovariectomized animals 
Plasma estrogen levels at one and three weeks after 
OVX were below the limit of reliable detection. At one 
week following OVX, uteri appeared pale and small. 
Cross-sectional area of immersion-fixed longitudinal 
smooth muscle was 1.0820.07 mm2. At three weeks 
post-OVX, the morphological appearance and size of the 
uterus were similar to those at one week post-OVX. 
Longitudinal smooth muscle cross-sectional area was 
1.17 +. 0.04 mm2 (not significant versus 1 week post- 
OVX). 
Nerve fibers immunoreactive for PGP 9.5 were most 
abundant within the longitudinal smooth muscle and 
around uterine blood vessels of OVX rats (Fig. 1 a). In 
longitudinal smooth muscle, they occupied 15.1+1.4% 
of the smooth muscle sectional area at one week post- 
OVX and 13.9?1.4% at three weeks post-OVX 
(difference not significant).  Total nerve area, as  
determined by multiplying longitudinal muscle cross- 
sectional area by percentage occupied by PGP-ir fibers, 
was 0.1620.01 mm2 at one week post-OVX, and 
0.1720.02 mm2 at three weeks (not significantly 
different). 
DBH-ir fibers were distributed similarly to PGP 9.5- 
ir fibers. These nerves occupied 9.820.5% of the smooth 
muscle area at one week post-OVX (Fig. Id),  and 
5.320.4% three weeks post-OVX. Total area of DBH-ir 
profiles in the longitudinal smooth muscle was 
0.13+-0.01 mm2 at one week post-OVX, and 0.0620.01 
mm2 at three weeks post-OVX. No statistical 
comparisons were made between groups because of 
differences in fixation methods. 
Acute estradiol treatment 
In rats 1 week after OVX, a single subcutaneous 
injection of 10 pg/kg 17-l3-estradiol raised serum levels 
to 738 2151 pg/ml at 30 minutes and 749275 pg/ml at 1 
hour after injection. At 24 hours after injection, uteri 
were enlarged and hyperemic, and longitudinal smooth 
muscle cross-sectional area in Zamboni-fixed tissue had 
increased to 1.7420.15 mm2 (p<O.OOl vs. vehicle). 
PGP 9.5-ir nerve density of longitudinal smooth 
muscle at this time was reduced by 72% relative to 
vehicle injection (Figs. lb, 2a, p<0.001) and total PGP-ir 
nerve area was decreased by 56% relative to placebo- 
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treated animals (Fig.2b, p<0.001). There was no 
discernible change in numbers of perivascular nerves 
relative to untreated ovariectomized specimens. 
Changes in longitudinal muscle innervation were 
even more pronounced for DBH-ir fibers. In rats treated 
acutely with estrogen, DBH-ir fiber density was 
2.2+0.6%, which represents an 85% reduction relative to 
that of placebo-injected controls (Fig. le ,  2a, p<0.001). 
Total DBH-ir nerve area was reduced by 69% 
(0.0420.01 mm2) relative to placebo-injected controls 
(Fig. 2b, p=0.002). Perivascular DBH-ir innervation 
appeared largely to be preserved. 
Chronic estradiol treatment 
In rats receiving estradiol-releasing pellets, serum 
estradiol was 220233 pglml 2 weeks after the 
implantation. Uteri of these animals were enlarged and 
hyperemic, and longitudinal smooth muscle cross- 
sectional area had increased to 2.4820.21 mm2 (p=0.001 
vs. OVX with placebo pellets and p=0.004 vs. acute 
estradiol). 
Density of PGP-ir fibers in longitudinal smooth 
muscle after 2 weeks of sustained estrogen 
administration was 1.7?0.7%, or 12% of density in rats 
receiving placebo pellets (Figs. Ic, 3a, p<0.001). Total 
area of PGP-immunoreactive nerve profiles was reduced 
by 76% to 0.0420.01 mm2 (Fig. 3b, p<0.001). There was 
no significant difference in total PGP-ir area between the 
two treatment protocols. In contrast to the longitudinal 
muscle, vascular innervation density appeared to be 
essentially unchanged. 
DBH-ir uterine nerves after chronic estrogen 
treatment occupied 0.9+0.2% of the longitudinal smooth 
muscle, which represents an 83% decrease relative to 
placebo-treated controls (Figs.lf, 3a, p<0.001). After 
normalizing for changes in the muscle size, total area of 
DBH-ir was decreased by 67% relative to vehicle-treated 
rats to 0.02220.004 mm2 (Fig. 3b, p=0.002). 
Perivascular DBH-ir nerves did not appear to be 
significantly reduced relative to placebo-implanted OVX 
rats. 
Discussion 
Uterine innervation after ovariectomy 
Ovariectomy for one to three weeks rendered serum 
estradiol levels to below the lower limit of reliable 
detection by our assay. Under these conditions. the 
uterus had undergone appreciable atrophy. as typically 
occurs following withdrawal of steroid support (Johnson 
and Everitt, 1988). Because longitudinal smooth muscle 
cross-sectional area was similar at one and three weeks, 
maximal atrophy apparently is achieved within one week 
of steroid withdrawal, with little or no additional change 
for at least 2 weeks thereafter. 
Despite their small size, uteri of OVX animals were 
well endowed with nerves. Dopamine 13-hydroxylase, a 
key enzyme in norepinephrine biosynthesis,  is a 
Fig. 1. Uterine innervation expressing immunoreactivity for the pan-neuronal marker Protein Gene Product (PGP) 9.5-ir (a-c) and the sympathetic 
neuronal marker dopamine B-hydroxylase (DBH, d-f). Staining was performed on transverse sections of uteri from rats 1 week following ovariectomy (a 
and d), 1 week ovariectomy plus a single injection of 17-13-estradiol 24 hours prior to harvesting tissue (b and e) and 3 weeks following ovariectomy 
and 2 weeks of chronic estrogen treatment (c and f). Arrows in b, d ,  and f indicate DBH-ir staining of perivascular nerve fibers. Bar: 50 urn. 
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selective and reliable marker commonly used to identify 
sympathetic innervation (Smith and Fan, 1996), and an 
abundance of fibers displaying this marker implies high 
numbers of sympathetic nerves and robust enzyme 
expression. On the other hand, PGP 9.5, a ubiquitin 
carboxyl-terminal hydrolase present in essentially all 
neural and neuroendocrine cells (Wilkinson et al., 1989). 
is expressed in all structurally intact axons (Lundberg et 
al., 1988; Haase et al., 1997; Li et al., 1997). Since the 
density and area of DBH-ir nerves at 1 week post-OVX 
was nearly 80% of that of PGP 9.5-ir nerves, it appears 
that the vast majority of nerves innervating the ovarian 
region of the uterine horn under low estrogen conditions 
derives from sympathetic neurons. It is also pertinent to 
note that the total uterine area occupied by nerves 
following ovariectomy for 1 week (0.16+0.01 mm2) or 3 
weeks (0.1720.02 mm2) are essentially identical to that 
measured previously in intact rats at diestrus (0.1520.03 
mm2) (Zoubina et al., 1998) when plasma estrogen is at 
its nadir in the estrous cycle. This suggests that the 
reduced estrogen level during diestrus is sufficient to 
induce maximal myometrial innervation which is not 
further increased by prolonged estrogen deprivation. It 
also implies that the surgical procedure for ovariectomy 
did not substantially or persistently interrupt major 
neural pathways traveling to this portion of the uterus. 
Effect of chronic estradiol treatment upon uterine 
innervation 
Estrogen supplementation by continuous release 
pellets increased plasma estradiol levels to values similar 
to those reported for mature rats during estrus (Cheng 
and Johnson, 1974; Viau and Meaney, 1991) and 
pregnancy (Bridges, 1984; Conrad et al., 1994). The 
efficacy of this treatment regimen was verified by 
observations that uteri were enlarged and hyperemic, and 
longitudinal smooth muscle cross-sectional area was 
increased. 
These changes in uterine morphology were 
accompanied by altered innervation. Estrogen 
supplementation for  2 weeks led to a substantial 
reduction in longitudinal smooth muscle DBH-ir 
sympathetic fibers. This reduction is consistent with 
0 lweek OVX 
KZZl acute E2 I 
PGP 9.541' DBH-ir 
Fig. 2. Quantitative analysis of uterine innervation in uteri from rats 1 
week following ovariectomy (OVX, N=4) and following a single injection 
of 17-D-estradiol 24 hours (acute E2, N=4) prior to harvesting tissue. 
PGP 9.5-ir and DBH-ir innervation is quantified as the percentage of 
sectional area occupied by immunoreactive fibers (Nerve Density) in 
panel a. In panel b, nerve density was multiplied by the total sectional 
area (mm2) to yield an estimate of total Nerve Area. 
PGP 9.541' DBH-ir 
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Fig. 3. Quantitative analysis of uterine innervation in uteri from rats at 3 
weeks following ovariectomy (OVX, N=7) and following 2 weeks of 17-0- 
estradiol supplementation (chronic E2, N=7) prior to harvesting tissue. 
PGP 9.5-ir and DBH-ir innervation was quantified as the percentage of 
sectional area occupied by immunoreactive fibers (Nerve Density) in 
panel a. Nerve density was multiplied by the total sectional area (mm2) 
to yield an estimate of total Nerve Area in panel b. 
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declines reported for norepinephrine and its biosynthetic 
enzymes after chronic estrogen treatment of prepubertal 
rats (Brauer et al., 1999a,b), and is reminiscent of the 
depletion of noradrenergic fibers seen in the pregnant 
uterus (Thorbert, 1978; Sporrong et al., 1981; Haase et 
al., 1997). In contrast to myometrial innervation, 
perivascular DBH-ir fibers seemed largely to be spared, 
a finding consistent with previous observations 
(Corbacho et al., 1997: Brauer et al., 1999a,b). 
The lower number of myometrial DBH-ir fibers in 
OVX rats receiving chronic estrogen replacement is 
attributable to an actual reduction in nerves rather than 
simply enzyme depletion. Hence, the abundant total 
innervation revealed by PGP 9.5 immunostaining at 1 
week post-OVX was dramatically reduced by 2 weeks of 
estrogen supplementation, and this decrease cannot be 
accounted for simply by increased uterine size. The 
present study did not investigate the cellular mechanisms 
leading to the loss of intact nerve fibers, but it is 
reasonable to suggest that terminal axonal degeneration 
must have played a role in the loss of these fibers, as 
occurs in pregnancy (Sporrong et al., 1978; Thorbert et 
al., 1978) and during the estrous cycle (Zoubina et al., 
1998). Accordingly, while multiple factors including 
elevated local progesterone levels (Bell and Malcolm, 
1978, 1988) and mechanical stretch (Lundberg et al., 
1989) are likely to contribute to uterine nerve 
degeneration in pregnancy, our observations support the 
notion that rising estrogen levels may also play a critical 
role in this process. They also suggest estrogen-induced 
reductions in uterine nerve density in prepubertal rats 
may be due, at least in part, to degenerative changes 
(Brauer et al., 1999a,b). The present findings therefore 
implicate estrogen as a mediator of the relatively long- 
term reductions in uterine sympathetic innervation seen 
in pregnancy and pubescence. 
Effect of acute estradiol treatment on uterine innervation 
While long-term estrogen administration leads to 
changes in uterine sympathetic innervation similar to 
those of pregnancy and puberty, the estrous cycle is 
characterized by much more rapid variations in uterine 
innervation. Marked axon degeneration and loss of 
sympathetic nerves occur over the course of 1-2 days 
(Zoubina et al., 1998; Zoubina and Smith, 2000) and is 
preceded by a relatively brief increase in plasma 
estrogen (Freeman, 1988). If the short-term increase in 
estrogen during the estrous cycle is responsible for nerve 
degeneration, it should be possible to initiate a similar 
decrease in sympathetic innervation using a treatment 
regimen that simulates the normal physiological rise 
during proestrus. Our measurements confirmed that a 
single injection of 10 pglkg estradiol increases plasma 
estrogen within 30 minutes to levels approximating 
those seen in the estrous cycle (Medlock et al., 1991; 
Viau and Meaney, 1991), and studies by others have 
shown that this peak is followed by a substantial decline 
at 6 hours and a return to baseline within 24 hours 
(Cheng and Johnson, 1974; Medlock et al., 1991). 
'This treatment regimen produced rapid changes in 
uterine size, confirming that effects on uterine 
morphology are manifest within 24 hours. Moreover, at 
this time numbers of both PGP 9.5-ir and DBH-ir nerves 
per uterine section were reduced by 56% and 69%, 
respectively, to a level comparable to that measured 
previously during estrus (Zoubina et al., 1998). These 
findings therefore confirm that an acute rise in estrogen 
induces myometrial nerve depletion with a timeframe 
similar to that occurring normally during the estrous 
cvcle (Zoubina et al., 1998: Zoubina and Smith, 2000) 
ahd in'the early stages of pregnancy (Sporrong et al.; 
1981). 
1; addition to showing that estrogen produces 
uterine nerve degeneration with a rapid time course, 
these findings argue against a role of several other 
hormones that also vary as a function of the estrous 
cycle. The estrous cycle rise in estrogen is followed by 
increased levels of luteinizing hormone, follicle 
stimulating hormone, progesterone and prolactin in late 
proestrus and estrus, and these might also act to decrease 
innervation density during estrus. However, in contrast 
to diestrus, ovariectomy is characterized by markedly 
elevated levels of luteinizing hormone and follicle 
stimulating hormone (Johnson and Everitt, 1988), 
indicating that high uterine nerve density is maintained 
despite increased levels of these hormones. Similarly, 
while prolactin and progesterone plasma levels are low 
after ovariectomy, acute estradiol treatment similar to 
that employed in this study is not accompanied by 
significant increases in these hormones (Johnson and 
Everitt, 1988; Viau and Meaney, 1991; Conrad et al.. 
1994). Therefore, our findings support the idea that 
circulating estrogen is the primary determinant of 
variations in uterine sympathetic innervation during the 
estrous cycle. 
Estrogen as a neurodegenerative agent 
The findings of the present study provide evidence 
that estrogen induces degeneration of terminal 
sympathetic fibers within the myometrium. This 
conclusion stands somewhat in contrast to literature 
showing that estrogen can protect central neurons from 
injury (Behl et al., 1997; Weaver et al., 1997; Sawada et 
al., 1998; Culmsee et al., 1999; Singer et al., 1999; Pike, 
1999) and promote axonal outgrowth (Kow and Pfaff, 
1973; Matsumoto and Arai, 1981; McEwen et al., 1991; 
Chowen et al., 1992; Honjo et al., 1992; Cambiasso et 
al., 1995; Tanzer and Jones, 1997: Toran-Allerand et al., 
1999). However, estrogen does induce death of some 
central neurons (Brawer et al., 1993), and in findings 
reminiscent of the present study, DBH-ir fibers in the 
primate prefrontal cortex are increased by ovariectomy 
and decreased by exogenous estrogen (Kritzer and 
Kohama, 1999). Therefore, estrogen can exert varied 
effects on different neuronal populations. Moreover, 
because estrogen causes myometrial sympathetic 
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innervation to degenerate while uterine perivascular 
innervation is spared, the effects of this hormone may 
differ with respect to homologous neurons projecting to 
different tar~ets .  
These Gried effects may be ascribed to estrogen's 
manifold  ac t ions ,  par t icular ly  wi th  regard to  
neurotrophic factors and their receptors. Sympathetic 
nerves depend upon neurotrophic factors for survival 
and outgrowth, and it is well established that estrogen 
can modulate neurotrophin synthesis (Siminoski et al., 
1987; Sohrabji et al., 1995; Gibbs, 1998), although the 
extent  t o  which this  occurs  in the  u te rus  d u r i n g  
pregnancy is at present uncertain (Naves et al., 1998; 
Brauer et al., 2000; Varol et al., 2000). Importantly, 
estrogen may also affect neuronal neurotrophin receptor 
expression (Sohrabji et al., 1994), thereby altering 
neuronal responsiveness to neurotrophins independent of 
changes in their absolute target levels. Consistent with 
this concept, neurotrophin receptor expression has been 
shown to decrease in humans during pregnancy (Naves 
e t  al . ,  1998) .  Al though  the  mechan i sm b y  which  
es t rogen c a n  induce se lec t ive  degenera t ion  of 
myometrial sympathetic innervation remains unresolved, 
hormone-induced modifications of neurotrophic proteins 
and their neuronal receptors would seem to be plausible 
candidates. 
Acknowledgments. This work was supported by NIH grant # NS 
NS39570 with core facilities provided by center grant HD02528 from the 
NICHD. The authors are indebted to Dr. Don Johnson for his helpful 
discussions concerning the estrogen treatment protocols. 
References 
Bell C. and Malcolm S.J. (1978). Observations on the loss of 
catecholamine fluorescence from intrauterine adrenergic nerves 
during pregnancy in the guinea-pig. J. Reprod. Fertil. 53, 51-58 
Bell C. and Malcolm S.J. (1988). Neurochemistry of the sympathetic 
innervation to the uterus. Clin. Exp. Pharmacol. Physiol. 15, 667-674 
Behl C., Skutella T., Lezoualc'h F., Post A., Widmann M,, Newton C.J. 
and Holsboer F. (1997). Neuroprotection against oxidative stress by 
estrogens: structure-activity relationship. Mol. Pharmacol. 51, 535- 
541. 
Brauer M.M., Lincoln J., Blundell D. and Corbacho A. (1992). Postnatal 
development of noradrenaline-containing nerves of the rat uterus. J. 
Auton. Nerv. Syst. 39, 37-50. 
Brauer M.M., Corbacho A.M. and Burnstock G. (1995). Effects of 
chronic and acute oestrogen treatment on the developing 
noradrenaline-containing nerves of the rat uterus. Int. J. Dev. 
Neurosci. 13, 791 -798. 
Brauer M.M., Llodra J., Scorza M.C., Chavez R., Burnstock G., 
Thrasivoulu C. and Cowen T. (1999a). Differential effects of 
prepubertal chronic oestrogen treatment on the synthesis of 
noradrenaline in uterine myometrial and perivascular sympathetic 
nerves. Int. J. Dev. Neurosci. 17, 295-303. 
Brauer M.M., Llodra J., Scorza M.C.. Chavez R., Burnstock G., 
Thrasivoulu C. and Cowen T. (1999b). Differential effects of 
prepubertal chronic oestrogen treatment on the synthesis of 
noradrenaline in uterine myometrial and perivascular sympathetic 
nerves. Int. J. Dev. Neurosci. 17, 295-303. 
Brauer M.M., Shockley K.P., Chavez R., Richeri A., Cowen T. and 
Crutcher K.A. (2000). The role of NGF in pregnancy-induced 
degeneration and regeneration of sympathetic nerves in the guinea 
pig uterus. J. Auton. New. Syst. 79, 19-27. 
Brawer J.R., Beaudet A., Desjardins G.C. and Schipper H.M. (1993). 
Pathologic effect of estradiol on the hypothalamus. Biol. Reprod. 49, 
647-652 
Bridges R.S. (1984). A quantitative analysis of the roles of dosage, 
sequence, and duration of estradiol and progesterone exposure in 
the regulation of maternal behavior in the rat. Endocrinology 114, 
930-940. 
Cambiasso M.J., Diaz H., Caceres A. and Carrer H.F. (1995). 
Neuritogenic effect of estradiol on rat ventromedial hypothalamic 
neurons CO-cultured with homotopic or heterotopic glia. J. Neurosci. 
Res. 42, 700-709. 
Cheng H.C. and Johnson D.C. (1974). Temporal changes in serum 
estradiol and prolactin in immature female rats given a single 
injection of estradiol benzoate. Steroids 24, 657-664. 
Chowen J.A., Torres-Aleman I. and Garcia-Segura L.M. (1992). Trophic 
effects of estradiol on fetal rat hypothalamic neurons. 
Neuroendocrinology 56, 895-901. 
Conrad K.P., Mosher M.D., Brinck-Johnsen T. and Colpoys M.C. (1994). 
Effects of 17 beta-estradiol and progesterone on pressor responses 
in conscious ovariectomized rats. Am. J. Physiol. 266. R1267- 
R1 272. 
Corbacho A.M., Brauer M.M. and Perez T. (1997). Development and 
maturation of noradrenaline-containing nerves of the rat uterine 
artery. Effects of acute and chronic oestrogen treatment. Int. J. Dev. 
Neurosci. 15, 363-371. 
Culmsee C., Vedder H., Ravati A., Junker V., Otto D., Ahlemeyer B., 
Krieg J.C. and Krieglstein J. (1999). Neuroprotection by estrogens in 
a mouse model of focal cerebral ischemia and in cultured neurons: 
evidence for a receptor-independent antioxidative mechanism. J. 
Cereb. Blood Flow Metab. 19, 1263-1269. 
Freeman M.E. (1988). The ovarian cycle of the rat. In: The physiology of 
reproduction. Knobil E. and Neil J. (eds). Raven Press. New York. 
pp 1893-1 928. 
Gibbs R.B. (1998). Levels of trkA and BDNF mRNA, but not NGF 
mRNA, fluctuate across the estrous cycle and increase in response 
to acute hormone replacement. Brain Res. 787, 259-268. 
Haase E.B., Buchman J., Tietz A.E. and Schramm L.P. (1997). 
Pregnancy-induced uterine neuronal degeneration in the rat. Cell 
Tissue Res. 288, 293-306. 
Honjo H., Tamura T., Matsumoto Y., Kawata M., Ogino Y., Tanaka K., 
Yamamoto T., Ueda S. and Okada H. (1992). Estrogen as a growth 
factor to central nervous cells. Estrogen treatment promotes 
development of acetylcholinesterase-positive basal forebrain 
neurons transplanted in the anterior eye chamber. J. Steroid 
Biochem. Mol. Biol 41, 633-635. 
Johnson M.H. and Everitt B.J. (1988). Anonymous. Essential 
reproduction. Blackwell Scientific Publications. Oxford. 
Kow L.M. and Pfaff D.W. (1973). Effects of estrogen treatment on the 
size of receptive field and response threshold of pudendal nerve in 
the female rat. Neuroendocrinology 13, 299-313. 
Kritzer M.F. and Kohama S.G. (1999). Ovarian hormones differentially 
influence immunoreactivity for dopamine beta-hydroxylase, choline 
acetyltransferase, and serotonin in the dorsolateral prefrontal cortex 
Estrogen modulates uterine innervation 
of adult rhesus monkeys. J. Comp. Neurol. 409, 438-451. 
Li G.L., Farooque M., Holtz A. and Olsson Y. (1997). Expression of the 
ubiquitin carboxyl-terminal hydrolase PGP 9.5 in axons following 
spinal cord compression trauma. An immunohistochemical study in 
the rat. APMlS 105, 384-390. 
Lundberg L.M., Alm P. and Thorbert G. (1989). Local mechanical effects 
and humoral factors evoke degeneration of guinea pig uterine 
innervation. Acta Obstet. Gynecol. Scand. 68, 487-496. 
Lundberg L.M., Alm P,, Wharton J. and Polak J.M. (1988). Protein gene 
product 9.5 (PGP 9.5). A new neuronal marker visualizing the whole 
uterine innervation and pregnancy-induced and developmental 
changes in the guinea pig. Histochemistry 90, 9-17. 
Matsumoto A. and Arai Y. (1981). Neuronal plasticity in the deafferented 
hypothalamic arcuate nucleus of adult female rats and its 
enhancement by treatment with estrogen. J. Comp. Neurol. 197, 
197-205. 
McEwen B.S., Coirini H., Westlind-Danielsson A., Frankfurt M,, Gould 
E., Schumacher M. and Woolley C. (1991). Steroid hormones as 
mediators of neural plasticity. J. Steroid Biochem. Mol. Biol. 39, 223- 
232. 
Medlock K.L., Forrester T.M. and Sheehan D.M. (1991). Short-term 
effects of physiological and pharmacological doses of estradiol on 
estrogen receptor and uterine growth. J. Recept. Res. 11, 743-756. 
Naves F.J., Vazquez M.T., San Jose I., Martinez-Almagro A. and Vega 
J.A. (1998). Pregnancy-induced denervation of the human uterine 
artery correlates with local decrease of NGF and TrkA. It. J. Anat. 
Embryol. 103, 279-290. 
Owman C. (1981). Pregnancy induces degenerative and regenerative 
changes in the autonomic innervation of the female reproductive 
tract. In: ClBA Foundation symposium 83: Symposium on 
development of the autonomic nervous system. Elliott K. and 
Lawrenson G. (eds). Pitman Medical. London. pp 252-279. 
Owrnan C., Alm P., Sjoberg N.O. and Stjernquist M. (1986). Structural, 
biochemical, and pharmacological aspects of the uterine autonomic 
innervation and its remodeling during pregnancy. In: The physiology 
and biochemistry of the uterus in pregnancy and labor. Huszar G. 
(ed). CRC Press. Boca Raton, Fla. pp 5-23. 
P~ke C.J. (1999). Estrogen modulates neuronal Bcl-XL expression and 
beta-amyloid-induced apoptosis: relevance to Alzheimer's disease. 
J. Neurochem. 72, 1552-1563 
Sawada H., Ibi M., Kihara T., Urushitani M,, Akaike A. and Shimohama 
S. (1998). Estradiol protects mesencephalic dopaminergic neurons 
from oxidative stress-induced neuronal death. J. Neurosci. Res. 54, 
707-71 9. 
Siminoski K., Murphy R.A., Rennert P. and Heinrich G. (1987). 
Cortisone, testosterone, and aldosterone reduce levels of nerve 
growth factor messenger ribonucleic acid In L-929 fibroblasts. 
Endocrinology 121, 1432-1 437. 
Simons E.J. and Smith P.G. (1994). Sensory and autonomic innervation 
of the rat eyelid: origins and peptide phenotypes. J. Chem. 
Neuroanat. 7, 35-47. 
Singer C.A., Figueroa-Masot X.A., Batchelor R.H. and Dorsa D.M. 
(1999). The mitogen-activated protein kinase pathway mediates 
estrogen neuroprotection after glutamate toxicity in primary cortical 
neurons. J. Neurosci. 19, 2455-2463. 
Sjoberg N.O. (1968). Considerations of the cause of disappearance of 
the adrenergic transmitter in uterine nerves during pregnancy. Acta 
physiol. Scand. 72, 510-517. 
Smith P.G. and Fan Q. (1996). Sympathetic nerve trajectories to rat 
orbital targets: role of connective tissue pathways. J. Comp. Neurol. 
365, 69-78. 
Sohrabji F., Miranda R.C. and Toran-Allerand C.D. (1994). Estrogen 
differentially regulates estrogen and nerve growth factor receptor 
mRNAs in adult sensory neurons. J. Neurosci. 14, 459-471. 
Sohrabji F., Miranda R.C. and Toran-Allerand C.D. (1995). Identification 
of a putative estrogen response element in the gene encoding brain- 
derived neurotrophic factor. Proc. Natl. Acad. Sci. USA 92. 11 110- 
11114. 
Sporrong B., Alm P,, Owman C., Sjoberg N.O. and Thorbert G. (1978). 
Ultrastructural evidence for adrenergic nerve degeneration in the 
guinea pig uterus during pregnancy. Cell Tissue Res. 195, 189-193. 
Sporrong B., Alm P,, Owman C., Sjoberg N.O. and Thorbert G. (1981). 
Pregnancy is associated with extensive adrenergic nerve 
degeneration in the uterus. An electronmicroscopic study in the 
guinea-pig. Neuroscience 6, 11 19-1 126 
Stefanini M,, DeMartino C. and Zamboni L. (1967). Fixation of 
ejaculated spermatozoa for electron microscopy. Nature 216, 173- 
1 74 
Tanzer L. and Jones K.J. (1997). Gonadal steroid regulation of hamster 
facial nerve regeneration: effects of dihydrotestosterone and 
estradiol. Exp. Neurol. 146, 258-264. 
Thorbert G. (1978). Regional changes in structure and funct~on of 
adrenergic nerves in guinea-pig uterus during pregnancy. Acta 
Obstet. Gynecol. Scand. 79, 1-32. 
Thorbert G., Alm P., Owman C., Sjoberg N.O. and Sporrong B. (1978). 
Regional changes in structural and functional integrity of myometrial 
adrenergic nerves in pregnant guinea-pig, and their relationship to 
the localization of the conceptus. Acta Physiol. Scand. 103, 120- 
131. 
Toran-Allerand C.D.,  Singh M. and Setalo G.J. (1999). Novel 
mechanisms of estrogen act~on in the brain: new players in an old 
story. Front. Neuroendocrinol. 20, 97-121. 
Varol F.G., Duchemin A., Neff N.H. and Hadjiconstantinou M. (2000). 
Nerve growth factor (NGF) and NGF mRNA change in rat uterus 
during pregnancy. Neurosci. Lett. 294, 58-62. 
Viau V. and Meaney M.J. (1991). Variations in the hypothalamic- 
pituitary-adrenal response to stress during the estrous cycle in the 
rat. Endocrinology 129, 2503-251 1. 
Weaver C.E.J., Park-Chung M., Gibbs T.T. and Farb D.H. (1997). 
17beta-Estradiol protects against NMDA-induced excitotoxicity by 
direct inhibition of NMDA receptors. Brain Res. 761, 338-341. 
Wilkinson K.D.. Lee K., Deshpande S., Duerksen-Hughes P,, Boss J.M. 
and Pohl J. (1989). The neuron-specific protein PGP 9.5 is a 
ubiquitin carboxyl-terminal hydrolase. Science 246, 670-673. 
Zoubina E.V. and Smith P.G. (2000). Axonal degeneration and 
regeneration in rat uterus during the estrous cycle. Auton. Neurosci. 
84, 176-1 85. 
Zoubina E.V., Fan Q. and Smith P.G. (1998). Variations ~n uter~ne 
innervation during the estrous cycle in rat. J. Comp. Neurol. 397, 
561 -571. 
Accepted May 14, 2001 
